Topics

Targeting Neuraminidase May Lead to Universal Flu Vaccine

08:00 EDT 28 Oct 2019 | Genetic Engineering News

Scripps Research study conducted jointly with Washington University School of Medicine in St. Louis and the Icahn School of Medicine at Mount Sinai in New York, points to a new approach to tackle severe cases of the flu, including pandemics.

The post Targeting Neuraminidase May Lead to Universal Flu Vaccine appeared first on GEN - Genetic Engineering and Biotechnology News.

Original Article: Targeting Neuraminidase May Lead to Universal Flu Vaccine

NEXT ARTICLE

More From BioPortfolio on "Targeting Neuraminidase May Lead to Universal Flu Vaccine"

Quick Search